Assessment of new lesions in [18F]FDG-PET/CT scans of metastatic breast cancer patients: A proposal for metastatic breast cancer imaging reporting and data systems (mBI-RADS)

被引：0
|
作者：
Hein, S. P. [1 ]
Jakobsen, N. M. [2 ]
Naghavi-Behzad, M. [2 ]
Weber, W. A. [1 ]
Vach, W. [3 ]
Hildebrandt, M. Grubbe [2 ,4 ]
Vogsen, M. [4 ,5 ]
机构：
[1] Tech Univ Munich, Dept Nucl Med, Munich, Germany
[2] Odense Univ Hosp, Dept Nucl Med, Odense, Denmark
[3] Basel Acad Qual & Res Med, Basel, Switzerland
[4] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[5] Odense Univ Hosp, Dept Oncol, Odense, Denmark
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0130
引用
收藏
页码：S480 / S480
页数：1
相关论文
共 50 条
  • [41] CIRCULATING TUMOR CELLS AND BONE METASTASES AS DETECTED BY FDG-PET/CT IN PATIENTS WITH METASTATIC BREAST CANCER
    De Giorgi, U.
    Valero, V.
    Rohren, E.
    Doyle, G. V.
    Ueno, N. T.
    Handy, B. C.
    Reuben, J. M.
    Cristofanilli, M.
    Macapinlac, H. A.
    Hortobagyi, G. N.
    ANNALS OF ONCOLOGY, 2009, 20 : 56 - 57
  • [42] Detecting Metastatic Patterns of Oligometastatic Breast Cancer: A Comparative Analysis of 18F-FDG PET/CT and Conventional CT Imaging
    Moser, Rebecca
    Pfeiffer, Sophie
    Cala, Lisena
    Klein, Evelyn
    Kiechle, Marion
    Behzadi, Sophie T.
    Fallenberg, Eva
    Combs, Stephanie E.
    Weber, Wolfgang
    Borm, Kai J.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (06) : 845 - 850
  • [43] CLINICAL VALUE OF 18(F)FDG-PET/CT FUSION IMAGING IN BREAST CANCER MANAGEMENT.
    Peepre, K.
    Kumar, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [44] Early assessment by PET with [18F]FDG of response to a recent protocol for first-line chemotherapy of metastatic breast cancer
    Mariani, G
    Gennari, A
    Giorgetti, A
    Donati, S
    Puccini, G
    Nista, N
    Dani, D
    Bengala, C
    Salvadori, PA
    Conti, PF
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1164 - 1164
  • [45] Investigating the radiomic signatures of metastatic and non-metastatic breast cancer patients based on F18-FDG PET/CT images
    Dirand, Anne-Sophie
    Orlhac, Fanny
    Boughdad, Sarah
    Champion, Laurence
    Nioche, Christophe
    Buvat, Irene
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [46] Added value of [18F]-FDG-PET in staging breast cancer and detection of relapse
    Landheer, M.
    Steffens, M.
    Klinkenbiji, J.
    Oyen, W.
    EJC SUPPLEMENTS, 2004, 2 (03): : 95 - 96
  • [47] Kinetic modeling of [18F]FES PET in patients with metastatic ER plus breast cancer
    Iqbal, Ramsha
    van Oordt, Catharina Menke-van der Houven
    Oprea-Lager, Daniela
    Schuit, Robert
    Windhorst, Albert
    Boellaard, Ronald
    Yaqub, Mohammed
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [48] Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI
    Kai Jannusch
    Frederic Dietzel
    Nils Martin Bruckmann
    Janna Morawitz
    Matthias Boschheidgen
    Peter Minko
    Ann-Kathrin Bittner
    Svjetlana Mohrmann
    Harald H. Quick
    Ken Herrmann
    Lale Umutlu
    Gerald Antoch
    Christian Rubbert
    Julian Kirchner
    Julian Caspers
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1451 - 1461
  • [49] Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers
    Gaeta, C. M.
    Vercher-Conejero, J. L.
    Sher, A. C.
    Kohan, A.
    Rubbert, C.
    Avril, N.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 57 (04): : 352 - 366
  • [50] Correction to: [18F]-FDG-PET/CT and [18F]-FAZA-PET/CT Hypoxia Imaging of Metastatic Thyroid Cancer: Association with Short-Term Progression after Radioiodine Therapy
    Masatoyo Nakajo
    Megumi Jinguji
    Atsushi Tani
    Yoriko Kajiya
    Tooru Nandate
    Ikumi Kitazano
    Takashi Yoshiura
    Molecular Imaging and Biology, 2020, 22 : 1621 - 1621
12345